Products

Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, is committed to transforming scientific discovery into advances in healthcare. The company's core capabilities include drug discovery, research, development, biomanufacturing, and a global commercial infrastructure.

Biogen Idec pursues the creativity of science with passion and discipline. For more than 25 years, the company has grown through the discovery, development and commercialization of its own innovative products and through strategic alliances.

Scientific excellence that achieves new standards of care drives the company's work. Over 20 products are currently in clinical development addressing a variety of key medical needs.

More